Key Events This Week
13 Apr: Stock opens at Rs.416.60, declines 0.71%
15 Apr: New 52-week high and all-time intraday high reached (Rs.445)
16 Apr: Price retreats by 3.17% to Rs.424.15
17 Apr: Week closes at Rs.427.60, up 0.81% on the day

SMS Pharmaceuticals Ltd Surges 7.01% to Day's High of Rs 445 — Outperforms Sector by 5.5 Percentage Points
2026-04-15 14:00:50The Sensex advanced 1.57% on 15 Apr 2026, yet SMS Pharmaceuticals Ltd outpaced the broader market with a 7.01% gain, reaching an intraday high of Rs 445. This 5.5-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market tailwind.
Read full news article
Broad-Based Technical Strength Lifts SMS Pharmaceuticals Ltd to 52-Week High of Rs 433.8
2026-04-15 09:44:16With a remarkable 106.56% gain over the past year, SMS Pharmaceuticals Ltd has surged to a new 52-week high of Rs 433.8, closing just 0.23% shy of this peak on 15 Apr 2026. This milestone reflects a sustained rally fuelled by strong technical momentum and a favourable market backdrop.
Read full news article
SMS Pharmaceuticals Ltd is Rated Hold by MarketsMOJO
2026-04-09 10:10:03SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.
Read full news article
SMS Pharmaceuticals Ltd Surges 7.38% to Day's High of Rs 389.8 — Outperforms Sector by 2.33 Percentage Points
2026-04-01 09:31:50The Sensex advanced 2.66% on 1 Apr 2026, yet SMS Pharmaceuticals Ltd outpaced the broader market with a 7.38% gain, reaching an intraday high of Rs 389.8. This 2.33 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift.
Read full news article
SMS Pharmaceuticals Ltd is Rated Hold by MarketsMOJO
2026-03-29 10:10:02SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news articleSMS Pharmaceuticals Gains 0.48%: 2 Key Factors Driving This Week’s Resilience
2026-03-28 15:08:38
Key Events This Week
23 Mar: Valuation shifts amid strong market performance
24 Mar: Intraday high with 7.82% surge
27 Mar: Week closes at Rs.386.55 (+0.48%)

SMS Pharmaceuticals Ltd Surges 7.82% to Day's High of Rs 397.3 — Outperforms Sector by 5.72 Percentage Points
2026-03-24 13:30:52The Sensex advanced 2.26% on 24 Mar 2026, yet SMS Pharmaceuticals Ltd outpaced the broader market with a robust 7.82% gain, touching an intraday high of Rs 397.3. This 5.72-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift.
Read full news articleSMS Pharmaceuticals Limited - Updates
13-Nov-2019 | Source : NSESMS Pharmaceuticals Limited has informed the Exchange regarding ''.
SMS Pharmaceuticals Limited - Updates
16-Oct-2019 | Source : NSESMS Pharmaceuticals Limited has informed the Exchange regarding ''.
Updates
18-Sep-2019 | Source : NSE
| SMS Pharmaceuticals Limited has informed the Exchange regarding ''. |
Corporate Actions
No Upcoming Board Meetings
SMS Pharmaceuticals Ltd has declared 40% dividend, ex-date: 22 Sep 25
SMS Pharmaceuticals Ltd has announced 1:10 stock split, ex-date: 17 Dec 15
No Bonus history available
No Rights history available







